Major Alzheimer's disease research centers are experiencing a $65 million funding gap largely due to delays caused by the Trump administration, which has postponed vital funding by failing to hold required scientific meetings. Despite legal rulings against government-wide funding freezes, the National Institutes of Health (NIH) faces cuts that jeopardize research in fields critical to public health, including Alzheimer's. With 6.7 million Americans affected, and numbers expected to double by 2060, these delays pose a serious threat to combating this widespread degenerative condition.
As the Trump administration seeks to reshape government and cut costs, scientific institutions like the NIH face funding delays that threaten critical research across fields.
The degenerative condition affects 6.7 million Americans, with diagnoses expected to double by 2060, emphasizing the need for sustained funding in Alzheimer's research.
Funding for Alzheimer's research centers is in jeopardy due to a $65 million gap, hindering progress towards combating a disease that is not considered normal aging.
Former NIH director Jeremy Berg states that the inability of advisory councils to meet has left many researchers unable to secure funding they are likely qualified for.
Collection
[
|
...
]